Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Alprolix
|
| gptkbp:activities |
factor VIII replacement therapy
|
| gptkbp:appointed_by |
intravenous injection
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinical_trial |
Phase 3
|
| gptkbp:developed_by |
gptkb:Pfizer
|
| https://www.w3.org/2000/01/rdf-schema#label |
eftrenonacog alfa
|
| gptkbp:indication |
prophylaxis of bleeding episodes
|
| gptkbp:is_used_for |
treatment of hemophilia A
|
| gptkbp:manager |
IV
|
| gptkbp:traded_on |
Efmoroctocog alfa
|